LALPATHLAB - Dr. Lal Path Labs Ltd.

Dr. Lal Path Labs Ltd. Share Market Related News
-: Stock News :- LALPATHLAB 10-06-2022 To 10-06-2022
-: Stock News :- LALPATHLAB 10-06-2022 To 10-06-2022

✔️ Margins in diagnostics business set to return to pre-Covid levels'
✔️ Margins in diagnostics business set to return to pre-Covid levels: Om Manchanda, Dr Lal Pathlabs

View Full Story
-: Stock News :- LALPATHLAB 06-06-2022 To 10-06-2022
-: Stock News :- LALPATHLAB 06-06-2022 To 10-06-2022

✔️ Trading strategies for Thyrocare, Dr Lal Path, Metropolis amid Covid scare
✔️ Margins in diagnostics business set to return to pre-Covid levels: Om Manchanda, Dr Lal Pathlabs

View Full Story
-: Stock News :- LALPATHLAB 19-05-2022 To 10-06-2022
-: Stock News :- LALPATHLAB 19-05-2022 To 10-06-2022

✔️ We aim to test 500,000 patients a day in 5 years: Dr Lal PathLabs CMD
✔️ Margins in diagnostics business set to return to pre-Covid levels: Om Manchanda, Dr Lal Pathlabs

View Full Story
-: Stock News :- LALPATHLAB 18-05-2022 To 17-05-2022
-: Stock News :- LALPATHLAB 18-05-2022 To 17-05-2022

✔️ Dr Lal Pathlabs slips 6%, hits 52-week low post muted Q4 results
✔️ Dr Lal Pathlabs reports 27 per cent dip in Q4 profit
✔️ Dr Lal Pathlabs Q4 consolidated PAT dips 27% to Rs 62 cr, stock sheds 1%

View Full Story
-: Stock News :- LALPATHLAB 05-04-2022 To 17-05-2022
-: Stock News :- LALPATHLAB 05-04-2022 To 17-05-2022

✔️ Dr Lal PathLabs announces pilot project to transport blood samples via drones
✔️ Dr Lal PathLabs unveils pilot project to transport blood samples via drones
✔️ Dr Lal Pathlabs Q4 consolidated PAT dips 27% to Rs 62 cr, stock sheds 1%

View Full Story
-: Stock News :- LALPATHLAB 21-03-2022 To 17-05-2022
-: Stock News :- LALPATHLAB 21-03-2022 To 17-05-2022

✔️ Dr Lal Pathlabs - Flat quarter but expanding pan India presence
✔️ Dr Lal PathLabs unveils pilot project to transport blood samples via drones
✔️ Dr Lal Pathlabs Q4 consolidated PAT dips 27% to Rs 62 cr, stock sheds 1%

View Full Story
-: Stock News :- LALPATHLAB 13-03-2022 To 17-05-2022
-: Stock News :- LALPATHLAB 13-03-2022 To 17-05-2022

✔️ Covid-19: Mizoram reports 357 new cases, three fatalities in last 24 hours
✔️ Dr Lal PathLabs unveils pilot project to transport blood samples via drones
✔️ Dr Lal Pathlabs Q4 consolidated PAT dips 27% to Rs 62 cr, stock sheds 1%

View Full Story
-: Stock News :- LALPATHLAB 21-02-2022 To 17-05-2022
-: Stock News :- LALPATHLAB 21-02-2022 To 17-05-2022

✔️ Dr Lal PathLabs, Metropolis Healthcare scramble new growth as covid cases wane
✔️ Dr Lal PathLabs unveils pilot project to transport blood samples via drones
✔️ Dr Lal Pathlabs Q4 consolidated PAT dips 27% to Rs 62 cr, stock sheds 1%

View Full Story
-: Stock News :- LALPATHLAB 20-02-2022 To 17-05-2022
-: Stock News :- LALPATHLAB 20-02-2022 To 17-05-2022

✔️ Covid-19 pandemic: Mizoram reports 1,324 new cases, one more death
✔️ Dr Lal PathLabs unveils pilot project to transport blood samples via drones
✔️ Dr Lal Pathlabs Q4 consolidated PAT dips 27% to Rs 62 cr, stock sheds 1%

View Full Story
-: Stock News :- LALPATHLAB 17-02-2022 To 17-05-2022
-: Stock News :- LALPATHLAB 17-02-2022 To 17-05-2022

✔️ Covid-19 pandemic: Mizoram reports 1,571 new cases and one death
✔️ Dr Lal PathLabs unveils pilot project to transport blood samples via drones
✔️ Dr Lal Pathlabs Q4 consolidated PAT dips 27% to Rs 62 cr, stock sheds 1%

View Full Story
-: Stock News :- LALPATHLAB 11-02-2022 To 17-05-2022
-: Stock News :- LALPATHLAB 11-02-2022 To 17-05-2022

✔️ Dr Lal PathLab Standalone December 2021 Net Sales at Rs 422.50 crore, down 1.08% Y-o-Y
✔️ Diagnostics chain Dr Lal PathLabs posts Rs 58 crore profit for Dec quarter
✔️ Dr Lal Pathlabs Q4 consolidated PAT dips 27% to Rs 62 cr, stock sheds 1%

View Full Story
-: Stock News :- LALPATHLAB 13-01-2022 To 17-05-2022
-: Stock News :- LALPATHLAB 13-01-2022 To 17-05-2022

✔️ LIC picks up stake in this healthcare stock in December quarter
✔️ Diagnostics chain Dr Lal PathLabs posts Rs 58 crore profit for Dec quarter
✔️ Dr Lal Pathlabs Q4 consolidated PAT dips 27% to Rs 62 cr, stock sheds 1%

View Full Story
-: Stock News :- LALPATHLAB 15-11-2021 To 17-05-2022
-: Stock News :- LALPATHLAB 15-11-2021 To 17-05-2022

✔️ Network effects
✔️ Diagnostics chain Dr Lal PathLabs posts Rs 58 crore profit for Dec quarter
✔️ Dr Lal Pathlabs Q4 consolidated PAT dips 27% to Rs 62 cr, stock sheds 1%

View Full Story
-: Stock News :- LALPATHLAB 28-10-2021 To 26-10-2021
-: Stock News :- LALPATHLAB 28-10-2021 To 26-10-2021

✔️ Lal PathLabs can fortify its hold if suburban is integrated well
✔️ We entered an otherwise hard market with Suburban deal: Dr Lal Pathlabs MD
✔️ Dr Lal PathLabs acquires Suburban Diagnostics in an all-cash deal
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 06-10-2021 To 26-10-2021
-: Stock News :- LALPATHLAB 06-10-2021 To 26-10-2021

✔️ Dr. Lal PathLabs Q2 PAT seen up 28.4% YoY to Rs 112 cr: Prabhudas Lilladher
✔️ We entered an otherwise hard market with Suburban deal: Dr Lal Pathlabs MD
✔️ Dr Lal PathLabs acquires Suburban Diagnostics in an all-cash deal
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 13-09-2021 To 26-10-2021
-: Stock News :- LALPATHLAB 13-09-2021 To 26-10-2021

✔️ Dr Lal PathLabs sees firm investor confidence driven by growth opportunities
✔️ We entered an otherwise hard market with Suburban deal: Dr Lal Pathlabs MD
✔️ Dr Lal PathLabs acquires Suburban Diagnostics in an all-cash deal
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 19-08-2021 To 26-10-2021
-: Stock News :- LALPATHLAB 19-08-2021 To 26-10-2021

✔️ Trade Spotlight: What should investors do with Dr Lal Pathlabs MindTree?
✔️ We entered an otherwise hard market with Suburban deal: Dr Lal Pathlabs MD
✔️ Dr Lal PathLabs acquires Suburban Diagnostics in an all-cash deal
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 04-08-2021 To 26-10-2021
-: Stock News :- LALPATHLAB 04-08-2021 To 26-10-2021

✔️ Dr Lal's growth prospects may be priced in the stock
✔️ We entered an otherwise hard market with Suburban deal: Dr Lal Pathlabs MD
✔️ Dr Lal PathLabs acquires Suburban Diagnostics in an all-cash deal
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 30-07-2021 To 26-10-2021
-: Stock News :- LALPATHLAB 30-07-2021 To 26-10-2021

✔️ Dr Lal PathLabs Q1 net profit zooms nearly 5-fold to Rs 133.7 crore
✔️ We entered an otherwise hard market with Suburban deal: Dr Lal Pathlabs MD
✔️ Dr Lal PathLabs acquires Suburban Diagnostics in an all-cash deal
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 19-06-2021 To 26-10-2021
-: Stock News :- LALPATHLAB 19-06-2021 To 26-10-2021

✔️ U'khand Police sets up SIT to probe fake Covid testing during Kumbh
✔️ We entered an otherwise hard market with Suburban deal: Dr Lal Pathlabs MD
✔️ Dr Lal PathLabs acquires Suburban Diagnostics in an all-cash deal
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 25-05-2021 To 26-10-2021
-: Stock News :- LALPATHLAB 25-05-2021 To 26-10-2021

✔️ For Dr Lal PathLabs, rising non-covid revenues, expansion aid growth
✔️ We entered an otherwise hard market with Suburban deal: Dr Lal Pathlabs MD
✔️ Dr Lal PathLabs acquires Suburban Diagnostics in an all-cash deal
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 21-05-2021 To 26-10-2021
-: Stock News :- LALPATHLAB 21-05-2021 To 26-10-2021

✔️ Dr Lal PathLabs Q4 net profit jumps over 2.5 times to Rs 85.1 crore
✔️ We entered an otherwise hard market with Suburban deal: Dr Lal Pathlabs MD
✔️ Dr Lal PathLabs acquires Suburban Diagnostics in an all-cash deal
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 17-05-2021 To 26-10-2021
-: Stock News :- LALPATHLAB 17-05-2021 To 26-10-2021

✔️ Stock picks by Sameet Chavan: Buy ITC, sell Dr Lal PathLabs
✔️ We entered an otherwise hard market with Suburban deal: Dr Lal Pathlabs MD
✔️ Dr Lal PathLabs acquires Suburban Diagnostics in an all-cash deal
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 20-04-2021 To 26-10-2021
-: Stock News :- LALPATHLAB 20-04-2021 To 26-10-2021

✔️ Near-term margin concerns and valuations weigh on Dr Lal Pathlabs
✔️ We entered an otherwise hard market with Suburban deal: Dr Lal Pathlabs MD
✔️ Dr Lal PathLabs acquires Suburban Diagnostics in an all-cash deal
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 18-04-2021 To 26-10-2021
-: Stock News :- LALPATHLAB 18-04-2021 To 26-10-2021

✔️ Dr Lal PathLabs shares show fatigue, following sharp rally
✔️ We entered an otherwise hard market with Suburban deal: Dr Lal Pathlabs MD
✔️ Dr Lal PathLabs acquires Suburban Diagnostics in an all-cash deal
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 06-04-2021 To 26-10-2021
-: Stock News :- LALPATHLAB 06-04-2021 To 26-10-2021

✔️ Trade Spotlight: What should investors do with Dr Lal Pathlabs, IndusInd Bank, Happiest Minds?
✔️ We entered an otherwise hard market with Suburban deal: Dr Lal Pathlabs MD
✔️ Dr Lal PathLabs acquires Suburban Diagnostics in an all-cash deal
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 23-03-2021 To 26-10-2021
-: Stock News :- LALPATHLAB 23-03-2021 To 26-10-2021

✔️ Sales recovery, expansion in new markets key to Dr Lal Pathlabs' growth
✔️ We entered an otherwise hard market with Suburban deal: Dr Lal Pathlabs MD
✔️ Dr Lal PathLabs acquires Suburban Diagnostics in an all-cash deal
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 18-01-2021 To 26-10-2021
-: Stock News :- LALPATHLAB 18-01-2021 To 26-10-2021

✔️ Dr. Lal PathLabs Q3 PAT seen up 27.4% YoY to Rs. 54.1 cr: Prabhudas Lilladher
✔️ We entered an otherwise hard market with Suburban deal: Dr Lal Pathlabs MD
✔️ Dr Lal PathLabs acquires Suburban Diagnostics in an all-cash deal
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 18-12-2020 To 26-10-2021
-: Stock News :- LALPATHLAB 18-12-2020 To 26-10-2021

✔️ Aarti Industries, Dr Lal Path Labs, HDFC AMC rise 2-4% on inclusion in FO
✔️ We entered an otherwise hard market with Suburban deal: Dr Lal Pathlabs MD
✔️ Dr Lal PathLabs acquires Suburban Diagnostics in an all-cash deal
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 10-11-2020 To 26-10-2021
-: Stock News :- LALPATHLAB 10-11-2020 To 26-10-2021

✔️ Dr Lal PathLabs, Thyrocare slip on profit booking on Covid vaccine optimism
✔️ We entered an otherwise hard market with Suburban deal: Dr Lal Pathlabs MD
✔️ Dr Lal PathLabs acquires Suburban Diagnostics in an all-cash deal
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 06-11-2020 To 26-10-2021
-: Stock News :- LALPATHLAB 06-11-2020 To 26-10-2021

✔️ Dr Lal PathLabs' Q2 net profit rises 6%, revenue up 18% YoY
✔️ We entered an otherwise hard market with Suburban deal: Dr Lal Pathlabs MD
✔️ Dr Lal PathLabs acquires Suburban Diagnostics in an all-cash deal
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 09-10-2020 To 26-10-2021
-: Stock News :- LALPATHLAB 09-10-2020 To 26-10-2021

✔️ Dr Lal PathLabs exposed data of millions of patients, including COVID-19 test results: Report
✔️ Data of millions of Dr Lal PathLabs patients exposed, including address, phone numbers, email ids
✔️ Dr Lal PathLabs acquires Suburban Diagnostics in an all-cash deal
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 08-10-2020 To 26-10-2021
-: Stock News :- LALPATHLAB 08-10-2020 To 26-10-2021

✔️ Trade Spotlight: Metropolis Healthcare, Dr Lal Pathlabs Ambuja Cement in focus
✔️ Data of millions of Dr Lal PathLabs patients exposed, including address, phone numbers, email ids
✔️ Dr Lal PathLabs acquires Suburban Diagnostics in an all-cash deal
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 09-08-2020 To 26-10-2021
-: Stock News :- LALPATHLAB 09-08-2020 To 26-10-2021

✔️ Margin pressures likely to cap upside for Dr Lal Pathlabs: Analysts
✔️ Data of millions of Dr Lal PathLabs patients exposed, including address, phone numbers, email ids
✔️ Dr Lal PathLabs acquires Suburban Diagnostics in an all-cash deal
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 08-08-2020 To 26-10-2021
-: Stock News :- LALPATHLAB 08-08-2020 To 26-10-2021

✔️ Sell Dr. Lal PathLabs; target of Rs 1006: Prabhudas Lilladher
✔️ Data of millions of Dr Lal PathLabs patients exposed, including address, phone numbers, email ids
✔️ Dr Lal PathLabs acquires Suburban Diagnostics in an all-cash deal
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 04-08-2020 To 26-10-2021
-: Stock News :- LALPATHLAB 04-08-2020 To 26-10-2021

✔️ Margin pressures to cap upside for Dr Lal Pathlabs as Covid dents volumes
✔️ Data of millions of Dr Lal PathLabs patients exposed, including address, phone numbers, email ids
✔️ Dr Lal PathLabs acquires Suburban Diagnostics in an all-cash deal
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 31-07-2020 To 26-10-2021
-: Stock News :- LALPATHLAB 31-07-2020 To 26-10-2021

✔️ Lal Pathlabs Q1 net down 52% to 28.4 crore
✔️ Dr Lal PathLabs June quarter net profit declines 52% to Rs 28.4 crore
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 19-05-2020 To 26-10-2021
-: Stock News :- LALPATHLAB 19-05-2020 To 26-10-2021

✔️ Sell Dr. Lal PathLabs; target of Rs 895: Prabhudas Lilladher
✔️ Dr Lal PathLabs June quarter net profit declines 52% to Rs 28.4 crore
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 21-04-2020 To 26-10-2021
-: Stock News :- LALPATHLAB 21-04-2020 To 26-10-2021

✔️ Broker's call: Dr Lal PathLabs (Buy)
✔️ Dr Lal PathLabs June quarter net profit declines 52% to Rs 28.4 crore
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 23-03-2020 To 26-10-2021
-: Stock News :- LALPATHLAB 23-03-2020 To 26-10-2021

✔️ Thyrocare Tech, Dr Lal Path Labs surge as pvt labs to conduct Covid-19 test
✔️ Dr Lal PathLabs June quarter net profit declines 52% to Rs 28.4 crore
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 18-03-2020 To 26-10-2021
-: Stock News :- LALPATHLAB 18-03-2020 To 26-10-2021

✔️ Thyrocare Tech, Dr Lal PathLabs rise 9% as govt allow private lab to do coronavirus testing
✔️ Dr Lal PathLabs June quarter net profit declines 52% to Rs 28.4 crore
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 05-02-2020 To 26-10-2021
-: Stock News :- LALPATHLAB 05-02-2020 To 26-10-2021

✔️ Broker's call: Dr Lal PathLabs
✔️ Dr Lal PathLabs June quarter net profit declines 52% to Rs 28.4 crore
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 03-02-2020 To 26-10-2021
-: Stock News :- LALPATHLAB 03-02-2020 To 26-10-2021

✔️ Dr Lal PathLab Standalone December 2019 Net Sales at Rs 310.40 crore, up 9.76% Y-o-Y
✔️ Dr Lal PathLabs Q3 net profit up 19% to Rs 54.9cr
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 25-11-2019 To 26-10-2021
-: Stock News :- LALPATHLAB 25-11-2019 To 26-10-2021

✔️ Lal Pathlabs says margins in second half will be lower, 'cash not a constraint'
✔️ Dr Lal PathLabs Q3 net profit up 19% to Rs 54.9cr
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 02-10-2019 To 26-10-2021
-: Stock News :- LALPATHLAB 02-10-2019 To 26-10-2021

✔️ Diagnostic players ride on changes in health insurance to beat slowdown
✔️ Dr Lal PathLabs Q3 net profit up 19% to Rs 54.9cr
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 01-10-2019 To 26-10-2021
-: Stock News :- LALPATHLAB 01-10-2019 To 26-10-2021

✔️ Dr Lal PathLabs' arm gets nod for signing binding term sheet
✔️ Dr Lal PathLabs Q3 net profit up 19% to Rs 54.9cr
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 14-08-2019 To 26-10-2021
-: Stock News :- LALPATHLAB 14-08-2019 To 26-10-2021

✔️ Volume growth key to Dr Lal Pathlab's health; stock rises over 4%
✔️ Dr Lal PathLabs Q3 net profit up 19% to Rs 54.9cr
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 21-07-2019 To 26-10-2021
-: Stock News :- LALPATHLAB 21-07-2019 To 26-10-2021

✔️ Preventive testing, Ayushman Bharat to drive diagnostic firms' revenues
✔️ Dr Lal PathLabs Q3 net profit up 19% to Rs 54.9cr
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 14-06-2019 To 26-10-2021
-: Stock News :- LALPATHLAB 14-06-2019 To 26-10-2021

✔️ Dr Lal PathLabs to acquire 70% stake in a new company
✔️ Dr Lal PathLabs to buy 70% stake in a new firm to strengthen presence in MP
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 15-04-2019 To 26-10-2021
-: Stock News :- LALPATHLAB 15-04-2019 To 26-10-2021

✔️ Metropolis Healthcare shares gain 9% over issue price on debut
✔️ Dr Lal PathLabs to buy 70% stake in a new firm to strengthen presence in MP
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 26-08-2018 To 26-10-2021
-: Stock News :- LALPATHLAB 26-08-2018 To 26-10-2021

✔️ Pricing pressures, regulatory worries for Dr Lal Pathlabs and Thyrocare
✔️ Dr Lal PathLabs to buy 70% stake in a new firm to strengthen presence in MP
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 14-05-2018 To 26-10-2021
-: Stock News :- LALPATHLAB 14-05-2018 To 26-10-2021

✔️ Dr Lal PathLabs Q4 net up 27%
✔️ Dr Lal PathLabs Q4 net up 27% at Rs 40 cr
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 31-03-2018 To 26-10-2021
-: Stock News :- LALPATHLAB 31-03-2018 To 26-10-2021

✔️ How Good Earth's journey led Anita Lal on a path of self-discovery
✔️ Dr Lal PathLabs Q4 net up 27% at Rs 40 cr
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 26-12-2017 To 26-10-2021
-: Stock News :- LALPATHLAB 26-12-2017 To 26-10-2021

✔️ Lab company results flag high valuations
✔️ Dr Lal PathLabs Q4 net up 27% at Rs 40 cr
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 09-11-2017 To 26-10-2021
-: Stock News :- LALPATHLAB 09-11-2017 To 26-10-2021

✔️ Dr Lal PathLabs Q2 profit dips 4% to Rs50.9 crore
✔️ Dr Lal PathLabs Q4 net up 27% at Rs 40 cr
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 08-08-2017 To 26-10-2021
-: Stock News :- LALPATHLAB 08-08-2017 To 26-10-2021

✔️ Q1 results: Dr Lal PathLabs' health improves
✔️ Signs of improvement for Dr Lal Pathlabs
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 07-08-2017 To 26-10-2021
-: Stock News :- LALPATHLAB 07-08-2017 To 26-10-2021

✔️ Lal Pathlabs net up 11% in Q1
✔️ Signs of improvement for Dr Lal Pathlabs
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 30-06-2017 To 26-10-2021
-: Stock News :- LALPATHLAB 30-06-2017 To 26-10-2021

✔️ Dr Lal PathLabs hits 52-week low after block deals
✔️ Signs of improvement for Dr Lal Pathlabs
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 06-04-2017 To 26-10-2021
-: Stock News :- LALPATHLAB 06-04-2017 To 26-10-2021

✔️ Dr Lal PathLabs eyes growth via acquisitions
✔️ Signs of improvement for Dr Lal Pathlabs
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 02-04-2017 To 26-10-2021
-: Stock News :- LALPATHLAB 02-04-2017 To 26-10-2021

✔️ Dr Lal PathLabs: Sample of success - Buy
✔️ Signs of improvement for Dr Lal Pathlabs
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 25-03-2017 To 26-10-2021
-: Stock News :- LALPATHLAB 25-03-2017 To 26-10-2021

✔️ Dr Lal Pathlabs' strong brand and network keep it in the pink of health
✔️ Signs of improvement for Dr Lal Pathlabs
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 17-03-2017 To 26-10-2021
-: Stock News :- LALPATHLAB 17-03-2017 To 26-10-2021

✔️ Star SME: The right diagnostics
✔️ Signs of improvement for Dr Lal Pathlabs
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 16-03-2017 To 26-10-2021
-: Stock News :- LALPATHLAB 16-03-2017 To 26-10-2021

✔️ Broker's Call
✔️ Signs of improvement for Dr Lal Pathlabs
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 01-03-2017 To 26-10-2021
-: Stock News :- LALPATHLAB 01-03-2017 To 26-10-2021

✔️ Metropolis' Ameera Shah resists listing
✔️ Signs of improvement for Dr Lal Pathlabs
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 02-02-2017 To 26-10-2021
-: Stock News :- LALPATHLAB 02-02-2017 To 26-10-2021

✔️ A closer look at the Q3 profit figures for Dr. Lal Pathlabs
✔️ Signs of improvement for Dr Lal Pathlabs
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 13-01-2017 To 26-10-2021
-: Stock News :- LALPATHLAB 13-01-2017 To 26-10-2021

✔️ Broker's call
✔️ Signs of improvement for Dr Lal Pathlabs
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 02-11-2016 To 26-10-2021
-: Stock News :- LALPATHLAB 02-11-2016 To 26-10-2021

✔️ Results of Dr Lal Path, MphasiS, ICRA, Geojit
✔️ Signs of improvement for Dr Lal Pathlabs
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 04-09-2016 To 26-10-2021
-: Stock News :- LALPATHLAB 04-09-2016 To 26-10-2021

✔️ Dr Lal Pathlabs: Test it out - Buy
✔️ Signs of improvement for Dr Lal Pathlabs
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 31-08-2016 To 26-10-2021
-: Stock News :- LALPATHLAB 31-08-2016 To 26-10-2021

✔️ Dr. Lal PathLabs hits new high; zooms 100% from issue price
✔️ Signs of improvement for Dr Lal Pathlabs
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 25-08-2016 To 26-10-2021
-: Stock News :- LALPATHLAB 25-08-2016 To 26-10-2021

✔️ Dr Lal PathLabs faces pricing pressure, margin erosion
✔️ Signs of improvement for Dr Lal Pathlabs
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 02-08-2016 To 26-10-2021
-: Stock News :- LALPATHLAB 02-08-2016 To 26-10-2021

✔️ Huge opportunity in healthcare segment in India: Dilip Bidani, Dr Lal Path Lab
✔️ Signs of improvement for Dr Lal Pathlabs
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 26-07-2016 To 26-10-2021
-: Stock News :- LALPATHLAB 26-07-2016 To 26-10-2021

✔️ ABC of Viral Hepatitis
✔️ Signs of improvement for Dr Lal Pathlabs
✔️ Dr Lal PathLabs Q1 profit falls 52% to Rs 28.4 crore
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 26-06-2016 To 26-10-2021
-: Stock News :- LALPATHLAB 26-06-2016 To 26-10-2021

✔️ Dr Lal PathLabs eyeing 18% growth in FY17
✔️ Dr Lal PathLabs eyeing 18 per cent growth in FY17
✔️ Dr Lal PathLabs eyeing 18 percent growth in fiscal year 2017
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 09-06-2016 To 26-10-2021
-: Stock News :- LALPATHLAB 09-06-2016 To 26-10-2021

✔️ Dr Lal PathLabs eyes wider footprint to drive growth
✔️ Dr Lal PathLabs eyes wider footprint to drive growth
✔️ Dr Lal PathLabs eyeing 18 percent growth in fiscal year 2017
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 31-05-2016 To 26-10-2021
-: Stock News :- LALPATHLAB 31-05-2016 To 26-10-2021

✔️ Buy Dr Lal Pathlabs, target Rs 1140: Citigroup
✔️ Dr Lal PathLabs eyes wider footprint to drive growth
✔️ Dr Lal PathLabs eyeing 18 percent growth in fiscal year 2017
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 27-05-2016 To 26-10-2021
-: Stock News :- LALPATHLAB 27-05-2016 To 26-10-2021

✔️ Dr Lal PathLabs Q4 net profit up 20 pct at Rs 34.44 crore
✔️ Dr Lal PathLabs to acquire Delta Ria and Pathology
✔️ Dr Lal PathLabs eyeing 18 percent growth in fiscal year 2017
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 09-05-2016 To 26-10-2021
-: Stock News :- LALPATHLAB 09-05-2016 To 26-10-2021

✔️ Splendid debut: Thyrocare Technologies lists at Rs 662 on BSE, a 48.4% premium over issue price
✔️ Dr Lal PathLabs to acquire Delta Ria and Pathology
✔️ Dr Lal PathLabs eyeing 18 percent growth in fiscal year 2017
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 13-04-2016 To 26-10-2021
-: Stock News :- LALPATHLAB 13-04-2016 To 26-10-2021

✔️ PVR, Dr Lal PathLabs, HDFC among top 5 stock picks of global brokerages
✔️ Dr Lal PathLabs to acquire Delta Ria and Pathology
✔️ Dr Lal PathLabs eyeing 18 percent growth in fiscal year 2017
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 03-03-2016 To 26-10-2021
-: Stock News :- LALPATHLAB 03-03-2016 To 26-10-2021

✔️ Dr. Lal PathLabs hits highest level since listing
✔️ Dr Lal PathLabs to acquire Delta Ria and Pathology
✔️ Dr Lal PathLabs eyeing 18 percent growth in fiscal year 2017
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 13-02-2016 To 26-10-2021
-: Stock News :- LALPATHLAB 13-02-2016 To 26-10-2021

✔️ Dr Lal PathLabs Q3 Profit More Than Doubles to Rs 61 Crore
✔️ Dr Lal PathLabs to acquire Delta Ria and Pathology
✔️ Dr Lal PathLabs eyeing 18 percent growth in fiscal year 2017
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 09-02-2016 To 26-10-2021
-: Stock News :- LALPATHLAB 09-02-2016 To 26-10-2021

✔️ Ushering A New Era
✔️ Dr Lal PathLabs to acquire Delta Ria and Pathology
✔️ Dr Lal PathLabs eyeing 18 percent growth in fiscal year 2017
✔️ Dr Lal PathLab Consolidated September 2021 Net Sales at Rs 498.40 crore, up 15.4% Y-o-Y
✔️ Dr Lal PathLabs Q2 net up 11% at Rs 96 cr; to acquire Suburban Diagnostics

View Full Story
-: Stock News :- LALPATHLAB 23-12-2015 To 22-12-2015
-: Stock News :- LALPATHLAB 23-12-2015 To 22-12-2015

✔️ Alkem Laboratories, Dr Lal Pathlabs shares list at hefty premium on debut
✔️ Dr Lal PathLabs, Alkem Lab extend rally after stellar debut
✔️ Alkem Labs, Dr Lal PathLabs soar on debut
✔️ 2015: The best year for primary market since 2010
✔️ Buy Sun Pharma, Avoid Dr Lal PathLabs, Says Mayuresh Joshi
✔️ Grand debut for Dr Lal PathLabs; shares zoom 50 per cent
✔️ Alkem, PathLabs soar in stellar debut on bourses
✔️ Alkem, Dr Lal make stellar debut on bourses
✔️ Alone and loving it: Lal Pathlabs and five other stock singles
✔️ Dr Lal PathLabs zooms 50% on debut
✔️ Dr Lal sees blockbuster listing
✔️ This Stock Soared Over 45% in Blockbuster Debut Today
✔️ Dr Lal PathLabs, Alkem Laboratories list on bourses, shares jump over 30 per cent
✔️ Dr Lal PathLabs lists at Rs 720 against issue price of Rs 550
✔️ Alkem, Dr Lal to make stock market debut tomorrow

View Full Story
-: Stock News :- LALPATHLAB 17-12-2015 To 22-12-2015
-: Stock News :- LALPATHLAB 17-12-2015 To 22-12-2015

✔️ Alkem, Dr Lal PathLabs to make stock market debut on December 23
✔️ Alkem, Dr Lal to make stock market debut on Dec 23
✔️ Alkem Labs, Dr Lal PathLabs soar on debut
✔️ 2015: The best year for primary market since 2010
✔️ Buy Sun Pharma, Avoid Dr Lal PathLabs, Says Mayuresh Joshi
✔️ Grand debut for Dr Lal PathLabs; shares zoom 50 per cent
✔️ Alkem, PathLabs soar in stellar debut on bourses
✔️ Alkem, Dr Lal make stellar debut on bourses
✔️ Alone and loving it: Lal Pathlabs and five other stock singles
✔️ Dr Lal PathLabs zooms 50% on debut
✔️ Dr Lal sees blockbuster listing
✔️ This Stock Soared Over 45% in Blockbuster Debut Today
✔️ Dr Lal PathLabs, Alkem Laboratories list on bourses, shares jump over 30 per cent
✔️ Dr Lal PathLabs lists at Rs 720 against issue price of Rs 550
✔️ Alkem, Dr Lal to make stock market debut tomorrow

View Full Story
-: Stock News :- LALPATHLAB 08-12-2015 To 07-12-2015
-: Stock News :- LALPATHLAB 08-12-2015 To 07-12-2015

✔️ IPOs of Dr Lal Pathlabs and Alkem Labs see good demand
✔️ Primary market gets a health care boost
✔️ Alkem, Dr Lal IPOs draw overwhelming response
✔️ Alkem, Dr Lal PathLabs IPO Get Strong Response
✔️ Healthcare floats draw strong investor response
✔️ IPOs: Dr Lal, Alkem fully subscribed
✔️ Alkem, Dr Lal IPOs oversubscribed a day before close
✔️ Lal PathLabs, Alkem Labs IPOs fully subscribed
✔️ Dr Lal PathLabs IPO oversubscribed
✔️ Dr Lal PathLabs IPO oversubscribed on day 2
✔️ Dr Lal PathLabs IPO Oversubscribed
✔️ Battle of IPOs: Harsh Roongta Picks Alkem Labs Over Dr Lal PathLabs
✔️ Alkem Labs subscribed 35%, Dr Lal PathLabs 65% on Day One
✔️ Dr Lal PathLabs IPO Opens: 10 Things to Know
✔️ PathLabs raises Rs 191 cr from anchor investors
✔️ Dr Lal PathLabs IPO Opens: 10 Things to Know
✔️ Alkem Labs, Dr Lal Pathlabs' IPOs: Good response from anchor investors
✔️ Dr Lal PathLabs Raises Rs 191 Crore From Anchor Investors
✔️ Dr Lal PathLabs: Diagnostics at a premium
✔️ Is PathLabs IPO worth a look? Heres what the brokerages say
✔️ Alkem Laboratories, Dr Lal Pathlabs IPOs to hit market tomorrow, should you invest?

View Full Story
-: Stock News :- LALPATHLAB 29-07-2022 To 29-07-2022
-: Stock News :- LALPATHLAB 29-07-2022 To 29-07-2022

✔️ We are focussed on productivity, says Dr Lal PathLabs MD

View Full Story
-: Stock News :- LALPATHLAB 28-07-2022 To 28-07-2022
-: Stock News :- LALPATHLAB 28-07-2022 To 28-07-2022

✔️ Dr Lal PathLabs Q1 net profit dips 57% to Rs 58 cr; revenue falls 17%
✔️ Dr Lal PathLabs Q1 net profit dips 57 per cent to 58 cr

View Full Story
-: Stock News :- LALPATHLAB 23-07-2022 To 28-07-2022
-: Stock News :- LALPATHLAB 23-07-2022 To 28-07-2022

✔️ Why this is the right time to sell Dr. Lal PathLabs stock
✔️ Dr Lal PathLabs Q1 net profit dips 57 per cent to 58 cr

View Full Story
-: Stock News :- LALPATHLAB 17-08-2022 To 17-08-2022
-: Stock News :- LALPATHLAB 17-08-2022 To 17-08-2022

✔️ Can Dr Lal Pathlabs carve out a new path?

View Full Story
-: Stock News :- LALPATHLAB 29-09-2022 To 29-09-2022
-: Stock News :- LALPATHLAB 29-09-2022 To 29-09-2022

✔️ Trade Spotlight | What should you do with India Cements, Dr Lal PathLabs, Glenmark Pharma on Thursday?

View Full Story

No More Records...